5-HTP, short for 5-hydroxytryptophan, is an amino acid the body makes from tryptophan and uses as the direct precursor to serotonin. Supplemental 5-HTP is extracted from the seeds of Griffonia simplicifolia, a West African plant, and has been sold as a dietary supplement in North America since the early 1990s, when production of pharmaceutical tryptophan was disrupted by an FDA action on contaminated batches and consumers and clinicians began looking for an alternative serotonin precursor. Most 5-HTP preparations on the market today contain 50, 100, or 200 mg of 5-HTP per capsule or tablet. The most studied benefits are in mood, sleep, fibromyalgia symptoms, and weight management, though the evidence varies in quality across these uses.
This article covers what 5-HTP actually does in the body, how long it takes to work, why some people feel better on it, why doctors do not prescribe it routinely, the main benefits, the side effects and interactions worth knowing, the recommended dosage, who should avoid it, and whether you can get 5-HTP from food. The intent is plain consumer education drawn from clinical literature, not promotion.
5-HTP raises serotonin levels in the brain and the gut. After ingestion, the supplement crosses the blood-brain barrier (unlike serotonin itself, which cannot cross it) and is converted by the enzyme aromatic L-amino acid decarboxylase into serotonin. Serotonin is a neurotransmitter that influences mood, appetite, sleep, pain perception, and several other functions, so raising its availability tends to produce effects across all of those domains rather than a single targeted change.
The pathway is the same one the body uses naturally: dietary tryptophan is converted to 5-HTP, which is converted to serotonin. Supplementing 5-HTP skips the first conversion step, which is typically the rate-limiting one, and delivers a more direct serotonin-building substrate than tryptophan alone. Serotonin produced from 5-HTP can also be further converted to melatonin in the pineal gland, which is part of why some users report better sleep along with mood effects.
Subjective effects on mood and anxiety often begin within one to two hours of an oral dose, as serotonin levels rise. Effects on sleep are typically reported within a few nights of starting an evening dose. Effects on depression symptoms, where they occur, usually take two to four weeks of daily use to become noticeable, which is roughly the same timeline as prescription antidepressants.
The half-life of 5-HTP in the body is short, around five hours, which is why dosing schedules typically split a daily total across two or three doses rather than a single morning dose. Insomnia-focused use concentrates the dose in the evening, when the serotonin-to-melatonin conversion supports the natural sleep cycle.
The most direct answer is that 5-HTP raises serotonin, and low serotonin activity is associated with low mood, irritability, poor sleep, and increased pain sensitivity in many people. Restoring serotonin availability tends to reverse the mood and sleep effects when low serotonin is part of the picture. People who feel a clear mood lift on 5-HTP are often those whose symptoms were partly serotonin-related.
This does not mean 5-HTP works for everyone with depression or anxiety. Mood disorders have multiple causes, and serotonin deficiency is one mechanism among several. People with depression rooted in other mechanisms (dopamine, inflammation, life circumstances) may notice little from 5-HTP. According to the National Institute of Mental Health, depression is influenced by “genetic, biological, environmental, and psychological factors,” which is why no single intervention works for everyone.
Three practical reasons. First, 5-HTP is sold as a dietary supplement in Canada and the US, not as a prescription drug, so there is no formal prescribing pathway. Doctors can recommend supplements, but the regulatory and pharmacy infrastructure does not match what exists for prescription medications. Second, the evidence base for 5-HTP in depression is smaller and weaker than the evidence base for prescription antidepressants like SSRIs. Most controlled trials have been small, short, and uneven in quality.
Third, 5-HTP has documented interactions with prescription antidepressants and other serotonin-active drugs. Combining 5-HTP with an SSRI, an SNRI, or an MAOI can raise serotonin to dangerous levels (serotonin syndrome), so physicians who do recommend 5-HTP do so cautiously and almost never alongside a prescription antidepressant. The combination of weaker evidence, regulatory limbo, and real interaction risk makes most physicians more comfortable prescribing what is on label.
The four uses with the most supporting evidence are mood, sleep, fibromyalgia, and weight management.
For mood, several small randomised trials found that 5-HTP can reduce symptoms of mild to moderate depression on its own. The combination of 5-HTP with conventional antidepressants may augment effects when used under medical supervision, though that combination requires care to avoid serotonin syndrome. Effect sizes from 5-HTP alone are modest and comparable to mild SSRIs in those trials, although the studies are smaller and shorter than the SSRI evidence base. Long-term administration of 5-HTP at therapeutic doses appears generally well tolerated, with most reported adverse effects limited to mild gastrointestinal symptoms.
For sleep, 5-HTP at evening doses (typically 100 to 300 mg taken thirty to sixty minutes before bed) has been shown to reduce sleep onset time and improve sleep quality in small studies. The mechanism is partly serotonergic and partly through serotonin’s conversion to melatonin. Research suggests that 5-HTP may help most when used daily for at least two weeks rather than taken occasionally.
For fibromyalgia, 5-HTP at doses of 300 to 400 mg per day has been studied for reducing pain intensity, morning stiffness, and anxiety. A small 1990 trial in Italy reported clinical improvement in most participants over thirty days; subsequent work has been intermittent but generally supportive.
For weight management, 5-HTP appears to increase satiety and reduce caloric intake at doses of 200 to 750 mg per day. Several small trials have shown that 5-HTP may increase fullness and produce modest weight loss in overweight participants, attributed partly to reduced appetite for carbohydrates specifically. Higher doses of 5-HTP were used in some of these studies, although most clinicians recommend the lower end of the range to limit side effects.
The most common acute side effects are gastrointestinal: nausea, soft stools, diarrhoea, and occasional stomach pain, particularly when starting at a higher dose. These usually resolve over a few days or by starting at a lower dose and increasing gradually.
The most serious risk is serotonin syndrome, a potentially dangerous condition caused by excessive serotonin activity. Symptoms include rapid heart rate, raised blood pressure, sweating, agitation, tremor, fever, and confusion. The risk is highest when 5-HTP is combined with prescription serotonin-active drugs (SSRIs, SNRIs, MAOIs, tramadol, certain migraine medications, lithium) or with other serotonin precursors. On its own at typical supplement doses, 5-HTP rarely causes serotonin syndrome.
A separate historical concern stems from a 1989 outbreak of eosinophilia-myalgia syndrome linked to contaminated batches of tryptophan, the upstream amino acid. A small number of EMS cases were later attributed to contaminated 5-HTP supplements as well. Modern 5-HTP supplements from reputable manufacturers have been free of the impurity (peak X) implicated in those cases, but the episode is part of why some clinicians remain cautious.
The clearest contraindications are anyone taking a prescription antidepressant (SSRI, SNRI, MAOI, tricyclic), anyone on lithium, anyone taking tramadol or certain migraine triptans, and anyone scheduled for surgery within the next two weeks. Pregnancy and breastfeeding are also commonly listed because the supplement has not been adequately studied in those populations.
People with active bipolar disorder should approach 5-HTP cautiously, because raising serotonin can sometimes precipitate manic episodes in vulnerable individuals. People with Parkinson’s disease who are taking carbidopa or levodopa should consult their physician before adding 5-HTP, since carbidopa blocks the conversion of 5-HTP to serotonin and may produce unexpected dosing dynamics.
Typical adult doses run from 50 to 400 mg per day, usually split across two or three doses to match the supplement’s short half-life. For sleep, 100 to 300 mg taken thirty to sixty minutes before bed is common. For mood, 100 mg three times a day is a frequent starting point in clinical trials, sometimes titrated up to 300 mg three times a day. For fibromyalgia, 300 to 400 mg per day in divided doses is the range used in published trials. For weight management, 200 to 750 mg per day in divided doses, typically twenty to thirty minutes before meals.
Most clinicians recommend starting at the low end of the range (50 to 100 mg per day) for the first week, both to allow tolerance to gastrointestinal side effects and to reduce the risk of serotonin-related symptoms. Many also recommend taking 5-HTP with a small amount of B-vitamin, particularly vitamin B6, which is a cofactor in the conversion of 5-HTP to serotonin.
Yes, in several clinically important ways. The most serious interactions are with prescription serotonergic drugs: SSRIs (sertraline, fluoxetine, citalopram, escitalopram, paroxetine), SNRIs (venlafaxine, duloxetine), MAOIs (phenelzine, tranylcypromine, selegiline), tramadol, dextromethorphan, and certain migraine triptans. Any of these combinations can produce serotonin syndrome.
Other interactions to know about: St. John’s Wort raises serotonin through a different mechanism and can compound effects when stacked with 5-HTP. Carbidopa, used in Parkinson’s disease treatment, blocks 5-HTP conversion. Alcohol may amplify 5-HTP’s sedative effects. The National Center for Complementary and Integrative Health notes that combining serotonin-raising substances can lead to a potentially life-threatening rise in the body’s serotonin levels, which is why the standard advice is to use 5-HTP alone rather than stacking it with other mood-active supplements.
Not in any meaningful amount. 5-HTP is an intermediate metabolite, not a direct food constituent. Foods high in tryptophan (turkey, chicken, milk, cheese, eggs, oats, nuts, seeds, soy) provide the upstream amino acid, but dietary tryptophan is mostly used for protein synthesis rather than serotonin production, and only a small fraction is converted to 5-HTP under normal conditions.
The supplemental form is extracted from Griffonia simplicifolia seeds, which contain natural 5-HTP at meaningful concentrations. This is the source for essentially all commercial 5-HTP supplements. There is no practical way to get a clinically relevant dose of 5-HTP from food.
No, but they are related. 5-HTP is the precursor to serotonin, and serotonin is the precursor to melatonin. Supplementing 5-HTP raises both serotonin and (indirectly) melatonin levels, which is one reason it has effects on both mood and sleep. Melatonin supplements raise melatonin directly and have stronger effects on circadian rhythm than 5-HTP.
Most people can, at typical supplement doses, and many users do for months at a time. Some clinicians recommend cycling (several weeks on, one or two weeks off) to maintain effectiveness, though the evidence for this practice is more practitioner experience than formal study.
No. Standard pre-employment drug panels do not test for 5-HTP or serotonin metabolites. The supplement does not produce false positives on the common five-panel or ten-panel tests.
No. 5-HTP does not produce dependence, tolerance develops slowly if at all at typical doses, and there is no withdrawal syndrome from stopping it.
Possibly, though the formal evidence for anxiety is weaker than for depression. Some users report reduced anxiety on 5-HTP, likely through the same serotonin pathway that affects depression. The National Institute of Mental Health notes that anxiety disorders are common (about a third of US adolescents and adults experience one at some point), and effective treatments include therapy, prescription medications, and lifestyle changes, with supplements like 5-HTP playing an adjunctive role at most.
